Skip to main content
Top
Published in: Abdominal Radiology 12/2021

01-12-2021 | Prostate Cancer | Pelvis

Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis

Authors: Christopher S. Lim, Jorge Abreu-Gomez, Rebecca Thornhill, Nick James, Ahmed Al Kindi, Andrew S. Lim, Nicola Schieda

Published in: Abdominal Radiology | Issue 12/2021

Login to get access

Abstract

Purpose

To evaluate if machine learning (ML) of radiomic features extracted from apparent diffusion coefficient (ADC) and T2-weighted (T2W) MRI can predict prostate cancer (PCa) diagnosis in Prostate Imaging-Reporting and Data System (PI-RADS) version 2.1 category 3 lesions.

Methods

This multi-institutional review board-approved retrospective case–control study evaluated 158 men with 160 PI-RADS category 3 lesions (79 peripheral zone, 81 transition zone) diagnosed at 3-Tesla MRI with histopathology diagnosis by MRI-TRUS-guided targeted biopsy. A blinded radiologist confirmed PI-RADS v2.1 score and segmented lesions on axial T2W and ADC images using 3D Slicer, extracting radiomic features with an open-source software (Pyradiomics). Diagnostic accuracy for (1) any PCa and (2) clinically significant (CS; International Society of Urogenital Pathology Grade Group ≥ 2) PCa was assessed using XGBoost with tenfold cross -validation.

Results

From 160 PI-RADS 3 lesions, there were 50.0% (80/160) PCa, including 36.3% (29/80) CS-PCa (63.8% [51/80] ISUP 1, 23.8% [19/80] ISUP 2, 8.8% [7/80] ISUP 3, 3.8% [3/80] ISUP 4). The remaining 50.0% (80/160) lesions were benign. ML of all radiomic features from T2W and ADC achieved area under receiver operating characteristic curve (AUC) for diagnosis of (1) CS-PCa 0.547 (95% Confidence Intervals 0.510–0.584) for T2W and 0.684 (CI 0.652–0.715) for ADC and (2) any PCa 0.608 (CI 0.579–0.636) for T2W and 0.642 (CI 0.614–0.0.670) for ADC.

Conclusion

Our results indicate ML of radiomic features extracted from T2W and ADC achieved at best moderate accuracy for determining which PI-RADS category 3 lesions represent PCa.
Appendix
Available only for authorised users
Literature
1.
go back to reference Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76:340-351CrossRef Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76:340-351CrossRef
2.
go back to reference Schieda N, Lim CS, Zabihollahy F et al (2021) Quantitative Prostate MRI. Journal of Magnetic Resonance Imaging 53:1632-1645CrossRef Schieda N, Lim CS, Zabihollahy F et al (2021) Quantitative Prostate MRI. Journal of Magnetic Resonance Imaging 53:1632-1645CrossRef
3.
go back to reference Purysko AS, Baroni RH, Giganti F et al (2020) PI-RADS Version 2.1: A Critical Review, From the AJR Special Series on Radiology Reporting and Data Systems. American Journal of Roentgenology 216:20-32CrossRef Purysko AS, Baroni RH, Giganti F et al (2020) PI-RADS Version 2.1: A Critical Review, From the AJR Special Series on Radiology Reporting and Data Systems. American Journal of Roentgenology 216:20-32CrossRef
4.
go back to reference Westphalen AC, McCulloch CE, Anaokar JM et al (2020) Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 296:76-84CrossRef Westphalen AC, McCulloch CE, Anaokar JM et al (2020) Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 296:76-84CrossRef
5.
go back to reference Barkovich EJ, Shankar PR, Westphalen AC (2019) A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores. AJR Am J Roentgenol 212:847-854CrossRef Barkovich EJ, Shankar PR, Westphalen AC (2019) A Systematic Review of the Existing Prostate Imaging Reporting and Data System Version 2 (PI-RADSv2) Literature and Subset Meta-Analysis of PI-RADSv2 Categories Stratified by Gleason Scores. AJR Am J Roentgenol 212:847-854CrossRef
6.
go back to reference Zhang L, Tang M, Chen S, Lei X, Zhang X, Huan Y (2017) A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol 27:5204-5214CrossRef Zhang L, Tang M, Chen S, Lei X, Zhang X, Huan Y (2017) A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer. Eur Radiol 27:5204-5214CrossRef
7.
go back to reference Rudolph MM, Baur ADJ, Cash H et al (2020) Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer. Sci Rep 10:15982 Rudolph MM, Baur ADJ, Cash H et al (2020) Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer. Sci Rep 10:15982
8.
go back to reference Otti VC, Miller C, Powell RJ, Thomas RM, McGrath JS (2019) The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer. BJU Int 123:82-90CrossRef Otti VC, Miller C, Powell RJ, Thomas RM, McGrath JS (2019) The diagnostic accuracy of multiparametric magnetic resonance imaging before biopsy in the detection of prostate cancer. BJU Int 123:82-90CrossRef
9.
go back to reference Schoots IG (2018) MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? Transl Androl Urol 7:70-82CrossRef Schoots IG (2018) MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions? Transl Androl Urol 7:70-82CrossRef
10.
go back to reference Maggi M, Panebianco V, Mosca A et al (2020) Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus 6:463-478CrossRef Maggi M, Panebianco V, Mosca A et al (2020) Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus 6:463-478CrossRef
11.
go back to reference Padhani AR, Barentsz J, Villeirs G et al (2019) PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology 292:464-474CrossRef Padhani AR, Barentsz J, Villeirs G et al (2019) PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology 292:464-474CrossRef
12.
go back to reference Felker ER, Raman SS, Margolis DJ et al (2017) Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary? AJR Am J Roentgenol 209:1272-1277CrossRef Felker ER, Raman SS, Margolis DJ et al (2017) Risk Stratification Among Men With Prostate Imaging Reporting and Data System version 2 Category 3 Transition Zone Lesions: Is Biopsy Always Necessary? AJR Am J Roentgenol 209:1272-1277CrossRef
13.
go back to reference Sheridan AD, Nath SK, Syed JS et al (2018) Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI. AJR Am J Roentgenol 210:347-357CrossRef Sheridan AD, Nath SK, Syed JS et al (2018) Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI. AJR Am J Roentgenol 210:347-357CrossRef
14.
go back to reference Washino S, Okochi T, Saito K et al (2017) Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naive patients. BJU Int 119:225-233CrossRef Washino S, Okochi T, Saito K et al (2017) Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naive patients. BJU Int 119:225-233CrossRef
15.
go back to reference Ullrich T, Quentin M, Arsov C et al (2018) Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate. J Urol 199:691-698CrossRef Ullrich T, Quentin M, Arsov C et al (2018) Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate. J Urol 199:691-698CrossRef
16.
go back to reference Hermie I, Van Besien J, De Visschere P, Lumen N, Decaestecker K (2019) Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center. Eur J Radiol 114:92-98CrossRef Hermie I, Van Besien J, De Visschere P, Lumen N, Decaestecker K (2019) Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center. Eur J Radiol 114:92-98CrossRef
17.
go back to reference Görtz M, Radtke JP, Hatiboglu G et al (2021) The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies. Eur Urol Focus 7:325-331CrossRef Görtz M, Radtke JP, Hatiboglu G et al (2021) The Value of Prostate-specific Antigen Density for Prostate Imaging-Reporting and Data System 3 Lesions on Multiparametric Magnetic Resonance Imaging: A Strategy to Avoid Unnecessary Prostate Biopsies. Eur Urol Focus 7:325-331CrossRef
18.
go back to reference Kan Y, Zhang Q, Hao J et al (2020) Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation. Eur Radiol 30:6274-6284CrossRef Kan Y, Zhang Q, Hao J et al (2020) Clinico-radiological characteristic-based machine learning in reducing unnecessary prostate biopsies of PI-RADS 3 lesions with dual validation. Eur Radiol 30:6274-6284CrossRef
19.
go back to reference Bonekamp D, Kohl S, Wiesenfarth M et al (2018) Radiomic Machine Learning for Characterization of Prostate Lesions with MRI: Comparison to ADC Values. Radiology 289:128-137CrossRef Bonekamp D, Kohl S, Wiesenfarth M et al (2018) Radiomic Machine Learning for Characterization of Prostate Lesions with MRI: Comparison to ADC Values. Radiology 289:128-137CrossRef
20.
go back to reference Chaddad A, Kucharczyk MJ, Cheddad A et al (2021) Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative Review. Cancers (Basel) 13 Chaddad A, Kucharczyk MJ, Cheddad A et al (2021) Magnetic Resonance Imaging Based Radiomic Models of Prostate Cancer: A Narrative Review. Cancers (Basel) 13
21.
go back to reference Woźnicki P, Westhoff N, Huber T et al (2020) Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters. Cancers (Basel) 12 Woźnicki P, Westhoff N, Huber T et al (2020) Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters. Cancers (Basel) 12
22.
go back to reference Giambelluca D, Cannella R, Vernuccio F et al (2021) PI-RADS 3 Lesions: Role of Prostate MRI Texture Analysis in the Identification of Prostate Cancer. Curr Probl Diagn Radiol 50:175-185CrossRef Giambelluca D, Cannella R, Vernuccio F et al (2021) PI-RADS 3 Lesions: Role of Prostate MRI Texture Analysis in the Identification of Prostate Cancer. Curr Probl Diagn Radiol 50:175-185CrossRef
23.
go back to reference Brancato V, Aiello M, Basso L et al (2021) Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions. Sci Rep 11:643CrossRef Brancato V, Aiello M, Basso L et al (2021) Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions. Sci Rep 11:643CrossRef
25.
go back to reference Vignati A, Mazzetti S, Giannini V et al (2015) Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Phys Med Biol 60:2685-2701CrossRef Vignati A, Mazzetti S, Giannini V et al (2015) Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Phys Med Biol 60:2685-2701CrossRef
26.
go back to reference Stanzione A, Cuocolo R, Cocozza S et al (2019) Detection of Extraprostatic Extension of Cancer on Biparametric MRI Combining Texture Analysis and Machine Learning: Preliminary Results. Acad Radiol 26:1338-1344CrossRef Stanzione A, Cuocolo R, Cocozza S et al (2019) Detection of Extraprostatic Extension of Cancer on Biparametric MRI Combining Texture Analysis and Machine Learning: Preliminary Results. Acad Radiol 26:1338-1344CrossRef
27.
go back to reference Lim C, Flood TA, Hakim SW et al (2016) Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma. J Magn Reson Imaging 43:726-736CrossRef Lim C, Flood TA, Hakim SW et al (2016) Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma. J Magn Reson Imaging 43:726-736CrossRef
28.
go back to reference Schwier M, van Griethuysen J, Vangel MG et al (2019) Repeatability of Multiparametric Prostate MRI Radiomics Features. Sci Rep 9:9441CrossRef Schwier M, van Griethuysen J, Vangel MG et al (2019) Repeatability of Multiparametric Prostate MRI Radiomics Features. Sci Rep 9:9441CrossRef
29.
go back to reference Hou Y, Bao ML, Wu CJ, Zhang J, Zhang YD, Shi HB (2020) A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions. Abdom Radiol (NY) 45:4223-4234CrossRef Hou Y, Bao ML, Wu CJ, Zhang J, Zhang YD, Shi HB (2020) A radiomics machine learning-based redefining score robustly identifies clinically significant prostate cancer in equivocal PI-RADS score 3 lesions. Abdom Radiol (NY) 45:4223-4234CrossRef
31.
go back to reference Lim C, Abreu-Gomez J, Leblond MA et al (2020) When to biopsy Prostate Imaging and Data Reporting System version 2 (PI-RADSv2) assessment category 3 lesions? Use of clinical and imaging variables to predict cancer diagnosis at targeted biopsy. Can Urol Assoc J.https://doi.org/10.5489/cuaj.6781 Lim C, Abreu-Gomez J, Leblond MA et al (2020) When to biopsy Prostate Imaging and Data Reporting System version 2 (PI-RADSv2) assessment category 3 lesions? Use of clinical and imaging variables to predict cancer diagnosis at targeted biopsy. Can Urol Assoc J.https://​doi.​org/​10.​5489/​cuaj.​6781
32.
go back to reference Abreu-Gomez J, Lim C, Cron GO, Krishna S, Sadoughi N, Schieda N (2021) Pharmacokinetic modeling of dynamic contrast-enhanced (DCE)-MRI in PI-RADS category 3 peripheral zone lesions: preliminary study evaluating DCE-MRI as an imaging biomarker for detection of clinically significant prostate cancers. Abdom Radiol (NY). https://doi.org/10.1007/s00261-021-03035-6 Abreu-Gomez J, Lim C, Cron GO, Krishna S, Sadoughi N, Schieda N (2021) Pharmacokinetic modeling of dynamic contrast-enhanced (DCE)-MRI in PI-RADS category 3 peripheral zone lesions: preliminary study evaluating DCE-MRI as an imaging biomarker for detection of clinically significant prostate cancers. Abdom Radiol (NY). https://​doi.​org/​10.​1007/​s00261-021-03035-6
33.
go back to reference van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 77:e104-e107CrossRef van Griethuysen JJM, Fedorov A, Parmar C et al (2017) Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 77:e104-e107CrossRef
34.
go back to reference Chen T, Guestrin C (2016) XGBoost: A Scalable Tree Boosting System Chen T, Guestrin C (2016) XGBoost: A Scalable Tree Boosting System
35.
go back to reference Schieda N, Nguyen K, Thornhill RE, McInnes MDF, Wu M, James N (2020) Importance of phase enhancement for machine learning classification of solid renal masses using texture analysis features at multi-phasic CT. Abdom Radiol (NY) 45:2786–2796 Schieda N, Nguyen K, Thornhill RE, McInnes MDF, Wu M, James N (2020) Importance of phase enhancement for machine learning classification of solid renal masses using texture analysis features at multi-phasic CT. Abdom Radiol (NY) 45:2786–2796
36.
go back to reference Hodgdon T, Thornhill RE, James ND, Beaulé PE, Speirs AD, Rakhra KS (2020) CT texture analysis of acetabular subchondral bone can discriminate between normal and cam-positive hips. Eur Radiol 30:4695–4704 Hodgdon T, Thornhill RE, James ND, Beaulé PE, Speirs AD, Rakhra KS (2020) CT texture analysis of acetabular subchondral bone can discriminate between normal and cam-positive hips. Eur Radiol 30:4695–4704
37.
go back to reference authors TG (2016) GPyOpt: A Bayesian Optimization framework in Python. authors TG (2016) GPyOpt: A Bayesian Optimization framework in Python.
38.
go back to reference Thornton C, Hutter F, Hoos HH, Leyton-Brown K Auto-WEKA: Combined selection and hyperparameter optimization of classification algorithms. ACM, pp 847–855 Thornton C, Hutter F, Hoos HH, Leyton-Brown K Auto-WEKA: Combined selection and hyperparameter optimization of classification algorithms. ACM, pp 847–855
39.
go back to reference Kohavi R (1995) A study of cross-validation and bootstrap for accuracy estimation and model selectionProceedings of the 14th international joint conference on Artificial intelligence - Volume 2. Morgan Kaufmann Publishers Inc., Montreal, Quebec, Canada, pp 1137–1143 Kohavi R (1995) A study of cross-validation and bootstrap for accuracy estimation and model selectionProceedings of the 14th international joint conference on Artificial intelligence - Volume 2. Morgan Kaufmann Publishers Inc., Montreal, Quebec, Canada, pp 1137–1143
40.
go back to reference Rosenkrantz AB, Meng X, Ream JM et al (2016) Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy. J Magn Reson Imaging 43:325-332CrossRef Rosenkrantz AB, Meng X, Ream JM et al (2016) Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy. J Magn Reson Imaging 43:325-332CrossRef
41.
go back to reference Schelb P, Kohl S, Radtke JP et al (2019) Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment. Radiology 293:607-617CrossRef Schelb P, Kohl S, Radtke JP et al (2019) Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment. Radiology 293:607-617CrossRef
42.
go back to reference Varghese B, Chen F, Hwang D et al (2019) Objective risk stratification of prostate cancer using machine learning and radiomics applied to multiparametric magnetic resonance images. Sci Rep 9:1570CrossRef Varghese B, Chen F, Hwang D et al (2019) Objective risk stratification of prostate cancer using machine learning and radiomics applied to multiparametric magnetic resonance images. Sci Rep 9:1570CrossRef
43.
go back to reference Zhong X, Cao R, Shakeri S et al (2019) Deep transfer learning-based prostate cancer classification using 3 Tesla multi-parametric MRI. Abdom Radiol (NY) 44:2030-2039CrossRef Zhong X, Cao R, Shakeri S et al (2019) Deep transfer learning-based prostate cancer classification using 3 Tesla multi-parametric MRI. Abdom Radiol (NY) 44:2030-2039CrossRef
44.
go back to reference Li J, Weng Z, Xu H et al (2018) Support Vector Machines (SVM) classification of prostate cancer Gleason score in central gland using multiparametric magnetic resonance images: A cross-validated study. Eur J Radiol 98:61-67CrossRef Li J, Weng Z, Xu H et al (2018) Support Vector Machines (SVM) classification of prostate cancer Gleason score in central gland using multiparametric magnetic resonance images: A cross-validated study. Eur J Radiol 98:61-67CrossRef
45.
go back to reference Li M, Yang L, Yue Y, Xu J, Huang C, Song B (2021) Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer. Frontiers in Oncology 10 Li M, Yang L, Yue Y, Xu J, Huang C, Song B (2021) Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer. Frontiers in Oncology 10
46.
go back to reference Nketiah GA, Elschot M, Scheenen TW et al (2021) Utility of T2-weighted MRI texture analysis in assessment of peripheral zone prostate cancer aggressiveness: a single-arm, multicenter study. Scientific Reports 11:2085CrossRef Nketiah GA, Elschot M, Scheenen TW et al (2021) Utility of T2-weighted MRI texture analysis in assessment of peripheral zone prostate cancer aggressiveness: a single-arm, multicenter study. Scientific Reports 11:2085CrossRef
47.
go back to reference Litjens GJ, Hambrock T, Hulsbergen-van de Kaa C, Barentsz JO, Huisman HJ (2012) Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness. Radiology 265:260-266CrossRef Litjens GJ, Hambrock T, Hulsbergen-van de Kaa C, Barentsz JO, Huisman HJ (2012) Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness. Radiology 265:260-266CrossRef
48.
go back to reference Schmeel FC (2019) Variability in quantitative diffusion-weighted MR imaging (DWI) across different scanners and imaging sites: is there a potential consensus that can help reducing the limits of expected bias? Eur Radiol 29:2243-2245CrossRef Schmeel FC (2019) Variability in quantitative diffusion-weighted MR imaging (DWI) across different scanners and imaging sites: is there a potential consensus that can help reducing the limits of expected bias? Eur Radiol 29:2243-2245CrossRef
49.
go back to reference Barrett T, Lawrence EM, Priest AN et al (2019) Repeatability of diffusion-weighted MRI of the prostate using whole lesion ADC values, skew and histogram analysis. Eur J Radiol 110:22-29CrossRef Barrett T, Lawrence EM, Priest AN et al (2019) Repeatability of diffusion-weighted MRI of the prostate using whole lesion ADC values, skew and histogram analysis. Eur J Radiol 110:22-29CrossRef
50.
go back to reference Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR (2019) Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. J Urol 202:506-510CrossRef Balakrishnan AS, Cowan JE, Cooperberg MR, Shinohara K, Nguyen HG, Carroll PR (2019) Evaluating the Safety of Active Surveillance: Outcomes of Deferred Radical Prostatectomy after an Initial Period of Surveillance. J Urol 202:506-510CrossRef
53.
go back to reference Wegelin O, Exterkate L, van der Leest M et al (2019) The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. Eur Urol 75:582-590CrossRef Wegelin O, Exterkate L, van der Leest M et al (2019) The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. Eur Urol 75:582-590CrossRef
Metadata
Title
Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict prostate cancer diagnosis
Authors
Christopher S. Lim
Jorge Abreu-Gomez
Rebecca Thornhill
Nick James
Ahmed Al Kindi
Andrew S. Lim
Nicola Schieda
Publication date
01-12-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03235-0

Other articles of this Issue 12/2021

Abdominal Radiology 12/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine